Dominantly inherited prion protein cerebral amyloidoses – a modern view of Gerstmann–Sträussler–Scheinker

Bernardino Ghetti, Pedro Piccardo, Gianluigi Zanusso

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Among genetically determined neurodegenerative diseases, the dominantly inherited prion protein cerebral amyloidoses are characterized by deposition of amyloid in cerebral parenchyma or blood vessels. Among them, Gerstmann–Sträussler–Scheinker disease has been the first to be described. Their clinical, neuropathologic, and molecular phenotypes are distinct from those observed in Creutzfeldt–Jakob disease (CJD) and related spongiform encephalopathies. It is not understood why specific mutations in the prion protein gene (PRNP) cause cerebral amyloidosis and others cause CJD. A significant neurobiologic event in these amyloidoses is the frequent coexistence of prion amyloid with tau neurofibrillary pathology, a phenomenon suggesting that similar pathogenetic mechanisms may be shared among different diseases in the sequence of events occurring in the cascade from amyloid formation to tau aggregation. This chapter describes the clinical, neuropathologic, and biochemical phenotypes associated with each of the PRNP mutations causing an inherited cerebral amyloidosis and emphasizes the variability of phenotypes.

Original languageEnglish (US)
Title of host publicationHandbook of Clinical Neurology
PublisherElsevier B.V.
Pages243-269
Number of pages27
ISBN (Print)9780444639455
DOIs
StatePublished - Jan 1 2018

Publication series

NameHandbook of Clinical Neurology
Volume153
ISSN (Print)0072-9752
ISSN (Electronic)2212-4152

Fingerprint

Amyloid
Phenotype
Mutation
Prions
Brain Diseases
Amyloidosis
Neurodegenerative Diseases
Genes
Blood Vessels
Pathology
Amyloid angiopathy
Prion Proteins

Keywords

  • amyloid
  • neuritic plaques
  • neurofibrillary tangles
  • prion disease
  • prion protein
  • PRNP
  • spongiform encephalopathy
  • tau protein
  • transmissibility

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Ghetti, B., Piccardo, P., & Zanusso, G. (2018). Dominantly inherited prion protein cerebral amyloidoses – a modern view of Gerstmann–Sträussler–Scheinker. In Handbook of Clinical Neurology (pp. 243-269). (Handbook of Clinical Neurology; Vol. 153). Elsevier B.V.. https://doi.org/10.1016/B978-0-444-63945-5.00014-3

Dominantly inherited prion protein cerebral amyloidoses – a modern view of Gerstmann–Sträussler–Scheinker. / Ghetti, Bernardino; Piccardo, Pedro; Zanusso, Gianluigi.

Handbook of Clinical Neurology. Elsevier B.V., 2018. p. 243-269 (Handbook of Clinical Neurology; Vol. 153).

Research output: Chapter in Book/Report/Conference proceedingChapter

Ghetti, B, Piccardo, P & Zanusso, G 2018, Dominantly inherited prion protein cerebral amyloidoses – a modern view of Gerstmann–Sträussler–Scheinker. in Handbook of Clinical Neurology. Handbook of Clinical Neurology, vol. 153, Elsevier B.V., pp. 243-269. https://doi.org/10.1016/B978-0-444-63945-5.00014-3
Ghetti B, Piccardo P, Zanusso G. Dominantly inherited prion protein cerebral amyloidoses – a modern view of Gerstmann–Sträussler–Scheinker. In Handbook of Clinical Neurology. Elsevier B.V. 2018. p. 243-269. (Handbook of Clinical Neurology). https://doi.org/10.1016/B978-0-444-63945-5.00014-3
Ghetti, Bernardino ; Piccardo, Pedro ; Zanusso, Gianluigi. / Dominantly inherited prion protein cerebral amyloidoses – a modern view of Gerstmann–Sträussler–Scheinker. Handbook of Clinical Neurology. Elsevier B.V., 2018. pp. 243-269 (Handbook of Clinical Neurology).
@inbook{48168f5efa8f4abc9abda8ad72347cfd,
title = "Dominantly inherited prion protein cerebral amyloidoses – a modern view of Gerstmann–Str{\"a}ussler–Scheinker",
abstract = "Among genetically determined neurodegenerative diseases, the dominantly inherited prion protein cerebral amyloidoses are characterized by deposition of amyloid in cerebral parenchyma or blood vessels. Among them, Gerstmann–Str{\"a}ussler–Scheinker disease has been the first to be described. Their clinical, neuropathologic, and molecular phenotypes are distinct from those observed in Creutzfeldt–Jakob disease (CJD) and related spongiform encephalopathies. It is not understood why specific mutations in the prion protein gene (PRNP) cause cerebral amyloidosis and others cause CJD. A significant neurobiologic event in these amyloidoses is the frequent coexistence of prion amyloid with tau neurofibrillary pathology, a phenomenon suggesting that similar pathogenetic mechanisms may be shared among different diseases in the sequence of events occurring in the cascade from amyloid formation to tau aggregation. This chapter describes the clinical, neuropathologic, and biochemical phenotypes associated with each of the PRNP mutations causing an inherited cerebral amyloidosis and emphasizes the variability of phenotypes.",
keywords = "amyloid, neuritic plaques, neurofibrillary tangles, prion disease, prion protein, PRNP, spongiform encephalopathy, tau protein, transmissibility",
author = "Bernardino Ghetti and Pedro Piccardo and Gianluigi Zanusso",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/B978-0-444-63945-5.00014-3",
language = "English (US)",
isbn = "9780444639455",
series = "Handbook of Clinical Neurology",
publisher = "Elsevier B.V.",
pages = "243--269",
booktitle = "Handbook of Clinical Neurology",

}

TY - CHAP

T1 - Dominantly inherited prion protein cerebral amyloidoses – a modern view of Gerstmann–Sträussler–Scheinker

AU - Ghetti, Bernardino

AU - Piccardo, Pedro

AU - Zanusso, Gianluigi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Among genetically determined neurodegenerative diseases, the dominantly inherited prion protein cerebral amyloidoses are characterized by deposition of amyloid in cerebral parenchyma or blood vessels. Among them, Gerstmann–Sträussler–Scheinker disease has been the first to be described. Their clinical, neuropathologic, and molecular phenotypes are distinct from those observed in Creutzfeldt–Jakob disease (CJD) and related spongiform encephalopathies. It is not understood why specific mutations in the prion protein gene (PRNP) cause cerebral amyloidosis and others cause CJD. A significant neurobiologic event in these amyloidoses is the frequent coexistence of prion amyloid with tau neurofibrillary pathology, a phenomenon suggesting that similar pathogenetic mechanisms may be shared among different diseases in the sequence of events occurring in the cascade from amyloid formation to tau aggregation. This chapter describes the clinical, neuropathologic, and biochemical phenotypes associated with each of the PRNP mutations causing an inherited cerebral amyloidosis and emphasizes the variability of phenotypes.

AB - Among genetically determined neurodegenerative diseases, the dominantly inherited prion protein cerebral amyloidoses are characterized by deposition of amyloid in cerebral parenchyma or blood vessels. Among them, Gerstmann–Sträussler–Scheinker disease has been the first to be described. Their clinical, neuropathologic, and molecular phenotypes are distinct from those observed in Creutzfeldt–Jakob disease (CJD) and related spongiform encephalopathies. It is not understood why specific mutations in the prion protein gene (PRNP) cause cerebral amyloidosis and others cause CJD. A significant neurobiologic event in these amyloidoses is the frequent coexistence of prion amyloid with tau neurofibrillary pathology, a phenomenon suggesting that similar pathogenetic mechanisms may be shared among different diseases in the sequence of events occurring in the cascade from amyloid formation to tau aggregation. This chapter describes the clinical, neuropathologic, and biochemical phenotypes associated with each of the PRNP mutations causing an inherited cerebral amyloidosis and emphasizes the variability of phenotypes.

KW - amyloid

KW - neuritic plaques

KW - neurofibrillary tangles

KW - prion disease

KW - prion protein

KW - PRNP

KW - spongiform encephalopathy

KW - tau protein

KW - transmissibility

UR - http://www.scopus.com/inward/record.url?scp=85048178865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048178865&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-63945-5.00014-3

DO - 10.1016/B978-0-444-63945-5.00014-3

M3 - Chapter

SN - 9780444639455

T3 - Handbook of Clinical Neurology

SP - 243

EP - 269

BT - Handbook of Clinical Neurology

PB - Elsevier B.V.

ER -